Frequent S100A4 expression with unique splicing pattern in gastric cancers: A hypomethylation event paralleled with E-cadherin reduction and Wnt activation

Translational Oncology

Volumn 1, Issue 4, 2008, Pages 165-176

  Li, Yan ^a   Zhang, Kai Li ^a   Sun, Yuan ^a   Yang, Yang ^a   Chen, Xiao Yan ^a   Kong, Q Y ^a   Wu, M L ^a   Liu, Jia ^a   Li, Hong ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349883134     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.08148     Document Type: Article

References (39)

1. Plummer M, Franceschi S, and Munoz N (2004). Epidemiology of gastric cancer. IARC Sci Publ 157, 311-326.
2. Yasuda K, Shiraishi N, Suematsu T, Yamaguchi K, Adachi Y, and Kitano S (1999). Rate of detection of lymph node metastasis is correlated with the depthof submucosal invasion in early stage gastric carcinoma. Cancer 85, 2119-2123.
3. Lee OJ, Hong SM, Razvi MH, Peng D, Powell SM, Smoklin M, Moskaluk AC, and El-Rifai W (2006). Expression of calcium-binding proteins S100A2 andS100A4 in Barrett's adenocarcinomas. Neoplasia 8, 843-850.
4. Zou M, Al-Baradie RS, Al-Hindi H, Farid NR, and Shi Y (2005). S100A4(Mts1) gene overexpression is associated with invasion and metastasis of papillarythyroid carcinoma. Br J Cancer 93, 1277-1284.
5. Grigorian M, Andresen S, Tulchinsky E, Kriajevska M, Carlberg C, Kruse C, Cohn M, Ambartsumian N, Christensen A, Selivanova G, et al. (2001). Tumorsuppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 276, 22699-22708.
6. Schäfer BWand Heizmann CW (1996). The S100 family of EF-hand calciumbindingproteins: functions and pathology. Trends Biochem Sci 21, 134-140.
7. Levett D, Flecknell PA, Rudland PS, Barraclough R, Neal DE, Mellon JK, andDavies BR (2002). Transfection of S100A4 produces metastatic variants of anorthotopic model of bladder cancer. Am J Pathol 160, 693-700.
8. Davies BR, Davies MP, Gibbs FE, Barraclough R, and Rudland PS (1993). Inductionof the metastatic phenotype by transfection of a benign rat mammaryepithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but notwith the oncogene EJ-ras-1. Oncogene 8, 999-1008.
9. Grum-Schwensen B, Klingelhofer J, Berg CH, El-Naaman C, Grigorian M, Lukanidin E, and Ambartsumian N (2005). Suppression of tumor developmentand metastasis formation in mice lacking the S100A4 gene. Cancer Res 65, 3772-3780.
10. Blencowe BJ (2006). Alternative splicing: new insights from global analyses. Cell126, 37-47.
11. Ambartsumian N, Tarabykina S, Grigorian M, Tulchinsky E, Hulgaard E, Georgiev G, and Lukanidin E (1995). Characterization of two splice variantsof metastasis-associated human mts1 gene. Gene 159, 125-130.
12. Albertazzi E, Cajone F, and Sherbet GV (1998). Characterization of a splicevariant of metastasis-associated h-mts1 (S100A4) gene expressed in human infiltratingcarcinomas of the breast. DNA Cell Biol 17, 1003-1008.
13. Tanaka M, Kitajima Y, Edakuni G, Sato S, and Miyazaki K (2002). Abnormalexpression of E-cadherin and beta-catenin may be a molecular marker of submucosalinvasion and lymph node metastasis in early gastric cancer. Br J Sur 89, 236-244.
14. Yonemura Y, Endou Y, Kimura K, Fushida S, Bandou E, Taniguchi K, Kinoshita K, Ninomiya I, Sugiyama K, Heizmann CW, et al. (2000). Inverse expression ofS100A4 and E-cadherin in associated with metastatic potential in gastric cancer. Clin Cancer Res 6, 4234-4242.
15. Stein U, Arlt F, Walther W, Smith J, Waldman T, Harris ED, Mertins SD, Heizmann CW, Allard D, Birchmeier W, et al. (2006). The metastasis-associated gene S100A4is a novel target of beta-catenin/T-cell factor signaling in colon cancer. Gastroenterology 131, 1486-1500.
16. Ateeq B, Unterberger A, Szyf M, and Rabbani SA (2008). Pharmacologicalinhibition of DNA methylation induces proinvasive and prometastatic genesin vitro and in vivo. Neoplasia 10, 266-278.
17. Xie R, Loose DS, Shipley GL, Xie S, Bassett RL Jr, and Broaddus RR (2007). Hypomethylation-induced expression of S100A4 in endometrial carcinoma. Mod Pathol 20, 1045-1054.
18. Li H, Sun Y, Kong QY, Zhang KL, Wang XW, Chen XY, Wang Q, and Liu J (2003). Combination of nucleic acid and protein isolation with tissue array construction:using defined histologic regions in single frozen tissue blocks for multipleresearch purposes. Int J Mol Med 12, 299-304.
19. Saleem M, Adhami VM, Ahmad N, Gupta S, and Mukhtar H (2005). Prognosticsignificance of metastasis-associated protein S100A4 (Mts1) in prostate cancerprogression and chemoprevention regimens in an autochthonous mousemodel. Clin Cancer Res 11, 147-153.
20. Cheng XX, Sun Y, Chen XY, Zhang KL, Kong QY, Liu J, and Li H (2004). Frequent translocalization of beta-catenin in gastric cancers and its relevance totumor progression. Oncol Rep 11, 1201-1207.
21. Rehman I, Goodarzi A, Cross SS, Leiblich A, Catto JW, Phillips JT, and Hamdy FC (2007). DNA methylation and immunohistochemical analysis of the S100A4calcium binding protein in human prostate cancer. Prostate 67, 341-347.
22. Lauren P (1965). The two histological main types of gastric carcinoma: diffuseand so-called intestinal type carcinoma, an attempt at a histoclinical classification. Acta Pathol Microbiol Scand 64, 31-49.
23. Cho YG, Nam SW, Kim TY, Kim YS, Kim CJ, Park JY, Lee JH, Kim HS, Lee JW, Park CH, et al. (2003). Overexpression of S100A4 is closely related to theaggressiveness of gastric cancer. APMIS 111, 539-545.
24. Hill R, Song Y, Cardiff RD, and Van Dyke T (2005). Selective evolution ofstromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 123, 1001-1011.
25. Kondo N, Ichimiya S, Tamura Y, Tonooka A, Koshiba S, Torigoe T, Kamiguchi K, Takenaga K, and Sato N (2005). A calcium binding protein, S100A4, mediatesT cell dependent cytotoxicity as a transformation-associated antigen. Microbiol Immunol 49, 49-56.
26. Schmidt-Hansen B, Ornås D, Grigorian M, Klingelhöfer J, Tulchinsky E, Lukanidin E, and Ambartsumian N (2004). Extracellular S100A4 (mts1) stimulatesinvasive growth of mouse endothelial cells and modulates MMP-13 matrixmetalloproteinase activity. Oncogene 23, 5487-5495.
27. Bhowmick NA, Neilson EG, and Moses HL (2004). Stromal fibroblasts in cancerinitiation and progression. Nature 432, 332-337.
28. Le Hir M, Hegyi I, Cueni-Loffing D, Loffing J, and Kaissling B (2005). Characterizationof renal interstitial fibroblast-specific protein 1/S100A4-positivecells in healthy and inflamed rodent kidneys. Histochem Cell Biol 123, 335-346.
29. Emberley ED, Murphy LC, and Watson PH (2004). S100 proteins and theirinfluence on pro-survival pathways in cancer. Biochem Cell Biol 82, 508-515.
30. Agerbaek M, Alsner J, Marcussen N, Lundbeck F, and Von der Maase H (2006). Focal S100A4 protein expression is an independent predictor of developmentof metastatic disease in cystectomized bladder cancer patients. Eur Uro l50, 777-785.
31. Li ZH and Bresnick AR (2006). The S100A4 metastasis factor regulates cellularmotility via a direct interaction with myosin-IIA. Cancer Res 66, 5173-5180.
32. Schmidt-Hansen B, Klingelhöfer J, Grum-Schwensen B, Christensen A, Andresen S, Kruse C, Hansen T, Ambartsumian N, Lukanidin E, and Grigorian M (2004). Functional significance of metastasis-inducing S100A4 (Mts1) in tumor-stroma interplay. J Biol Chem 279, 24498-24504.
33. Cajone F and Sherbet GV (1999). Stathmin is involved in S100A4-mediatedregulation of cell cycle progression. Clin Exp Metastasis 17, 865-871.
34. Venables JP (2004). Aberrant and alternative splicing in cancer. Cancer Res 64, 7647-7654.
35. Nelson WJ and Nusse R (2004). Convergence of Wnt, beta-catenin, and cadherinpathways. Science 303, 1483-1487.
36. Cheng XX, Wang ZC, Chen XY, Sun Y, Kong QY, Liu J, Gao X, Guan HW, and Li H (2005). Frequent loss of membranous E-cadherin in gastric cancer: across talk with Wnt in determining the fate of β-catenin. Clin Exp Metastasis 22, 85-93.
37. Garrett SC, Varney KM, Weber DJ, and Bresnick AR (2006). S100A4, a mediatorof metastasis. J Biol Chem 281, 677-680.
38. Deng GR, Lu YY, Chen SM, Miao J, Lu GR, Li H, Cai H, Xu XL E Z, and Liu PN (1987). Activated c-Ha-ras oncogene with a guanine to thymine transversionat the twelfth codon in a human stomach cancer cell line. Cancer Res 47, 3195-3198.
39. Rosty C, Ueki T, Argani P, Jansen M, Yeo CJ, Cameron JL, Hruban RH, andGoggins M (2002). Overexpression of S100A4 in pancreatic ductal denocarcinomasis associated with poor differentiation and DNA hypomethylation. Am J Pathol 160, 45-50.